Screener
Eligibility screening
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer
1 US site in TX
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer
1 US site in TX
Before we begin
Your answer affects how the questions are phrased.